Cell Processing Instruments Market 2030: The Rise of Automated Solutions in Healthcare
The global cell processing instruments market size was estimated at USD 6.06 billion in 2023 and is projected to grow at a CAGR of 7.04% from 2024 to 2030. The market growth can be attributed to the rising prevalence of chronic diseases, increasing investments in research and development, and the growing number of clinical trials for cell-based therapies. Moreover, the increasing number of collaborations, and partnerships amongst market players is also expected to have a positive impact on market growth. For instance, in February 2024, Thermo Fisher Scientific Inc. and Multiply Labs expanded their partnership. It aims to automate cell therapy production through a combination of robotics and automation of instruments. This is to reduce the amount of manufacturing space needed to produce cell therapies. The market has a positive impact during the pandemic. Several factors such as the growing demand for vaccines and therapeutics accelerated the market growth over the COVID period. More...